These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7102998)

  • 1. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 7. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
    Grambau GR; Johnson CE; Conlon PF; Weg JG
    J Clin Pharmacol; 1985; 25(5):381-3. PubMed ID: 4031115
    [No Abstract]   [Full Text] [Related]  

  • 9. Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrations.
    Munro CS; Prowse K
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):354-5. PubMed ID: 6432095
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline serum levels and theophylline clearance in asthmatic patients (author's transl)].
    Pastor MC; Sabaté I; Torres JM; Corominas M; Fortuny M; Planells P
    Med Clin (Barc); 1982 Jul 1-31; 79(3):126-8. PubMed ID: 7109768
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral aminophylline therapy. Increased dosage requirements in children.
    Zaske DE; Miller KW; Strem EL; Austrian S; Johnson PB
    JAMA; 1977 Apr; 237(14):1453-5. PubMed ID: 576637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of the pharmacokinetic determination of theophylline].
    Gao L
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):137-40, 188. PubMed ID: 3094865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of enoxacin on theophylline pharmacokinetics].
    Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):106-8, 128. PubMed ID: 1394590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring serum concentrations of theophylline during aminophylline infusion therapy].
    Prazáková J; Vondra V
    Cas Lek Cesk; 1985 Oct; 124(43):1332-5. PubMed ID: 4084951
    [No Abstract]   [Full Text] [Related]  

  • 18. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral aminophylline on lung mucociliary clearance in man.
    Sutton PP; Pavia D; Bateman JR; Clarke SW
    Chest; 1981 Dec; 80(6 Suppl):889-92. PubMed ID: 7030662
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.